• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非脂类碱性激动剂激活强效溶血磷脂酸受体 1 的结构机制。

Structural mechanisms of potent lysophosphatidic acid receptor 1 activation by nonlipid basic agonists.

机构信息

Department of Biological Sciences, Graduate School of Science, The University of Tokyo, Bunkyo, Tokyo, 113-0033, Japan.

出版信息

Commun Biol. 2024 Nov 6;7(1):1444. doi: 10.1038/s42003-024-07152-y.

DOI:10.1038/s42003-024-07152-y
PMID:39506093
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11541586/
Abstract

Lysophosphatidic acid receptor 1 (LPA) is one of the G protein-coupled receptors activated by the lipid mediator, lysophosphatidic acid (LPA). LPA is associated with a variety of diseases, and LPA agonists have potential therapeutic value for treating obesity and depression. Although potent nonlipid LPA agonists have recently been identified, the mechanisms of nonlipid molecule-mediated LPA activation remain unclear. Here, we report a cryo-electron microscopy structure of the human LPA-G complex bound to a nonlipid basic agonist, CpY, which has 30-fold higher agonistic activity as compared with LPA. Structural comparisons of LPA with other lipid GPCRs revealed that the negative charge in the characteristic binding pocket of LPA allows the selective recognition of CpY, which lacks a polar head. In addition, our structure show that the ethyl group of CpY directly pushes W271 to fix the active conformation. Endogenous LPA lacks these chemical features, which thus represent the crucial elements of nonlipid agonists that potently activate LPA. This study provides detailed mechanistic insights into the ligand recognition and activation of LPA by nonlipid agonists, expanding the scope for drug development targeting the LPA receptors.

摘要

溶血磷脂酸受体 1(LPA1)是一种 G 蛋白偶联受体,可被脂质介质溶血磷脂酸(LPA)激活。LPA 与多种疾病有关,LPA 激动剂在治疗肥胖症和抑郁症方面具有潜在的治疗价值。尽管最近已经确定了有效的非脂类 LPA 激动剂,但非脂类分子介导的 LPA 激活机制仍不清楚。在这里,我们报告了与非脂类碱性激动剂 CpY 结合的人 LPA-G 复合物的冷冻电子显微镜结构,CpY 的激动活性比 LPA 高 30 倍。LPA 与其他脂质 GPCR 的结构比较表明,LPA 特征结合口袋中的负电荷允许对缺乏极性头部的 CpY 进行选择性识别。此外,我们的结构表明,CpY 的乙基基团直接推动 W271 以固定活性构象。内源性 LPA 缺乏这些化学特征,这代表了强力激活 LPA 的非脂类激动剂的关键要素。这项研究为非脂类激动剂对 LPA 的配体识别和激活提供了详细的机制见解,为针对 LPA 受体的药物开发扩展了范围。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0e2/11541586/bb3b9ebd6ffc/42003_2024_7152_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0e2/11541586/b9443fa5111a/42003_2024_7152_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0e2/11541586/27a11f6ff531/42003_2024_7152_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0e2/11541586/3f9ef1ea9d41/42003_2024_7152_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0e2/11541586/37c4ee18eca2/42003_2024_7152_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0e2/11541586/bb3b9ebd6ffc/42003_2024_7152_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0e2/11541586/b9443fa5111a/42003_2024_7152_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0e2/11541586/27a11f6ff531/42003_2024_7152_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0e2/11541586/3f9ef1ea9d41/42003_2024_7152_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0e2/11541586/37c4ee18eca2/42003_2024_7152_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0e2/11541586/bb3b9ebd6ffc/42003_2024_7152_Fig5_HTML.jpg

相似文献

1
Structural mechanisms of potent lysophosphatidic acid receptor 1 activation by nonlipid basic agonists.非脂类碱性激动剂激活强效溶血磷脂酸受体 1 的结构机制。
Commun Biol. 2024 Nov 6;7(1):1444. doi: 10.1038/s42003-024-07152-y.
2
Lysophosphatidic Acid Receptor Agonism: Discovery of Potent Nonlipid Benzofuran Ethanolamine Structures.溶血磷脂酸受体激动剂:强效非脂质苯并呋喃乙醇胺结构的发现。
J Pharmacol Exp Ther. 2020 Aug;374(2):283-294. doi: 10.1124/jpet.120.265454. Epub 2020 May 14.
3
Structure of the active G-coupled human lysophosphatidic acid receptor 1 complexed with a potent agonist.活性 G 偶联人溶血磷脂酸受体 1 与有效激动剂复合物的结构。
Nat Commun. 2022 Sep 15;13(1):5417. doi: 10.1038/s41467-022-33121-2.
4
Lys39-Lysophosphatidate Carbonyl Oxygen Interaction Locks LPA1 N-terminal Cap to the Orthosteric Site and partners Arg124 During Receptor Activation.赖氨酸39-溶血磷脂酸羰基氧相互作用在受体激活过程中将LPA1的N端帽锁定到正构位点并与精氨酸124相互作用。
Sci Rep. 2015 Aug 13;5:13343. doi: 10.1038/srep13343.
5
Positive and Negative Cross-Talk between Lysophosphatidic Acid Receptor 1, Free Fatty Acid Receptor 4, and Epidermal Growth Factor Receptor in Human Prostate Cancer Cells.溶血磷脂酸受体1、游离脂肪酸受体4与表皮生长因子受体在人前列腺癌细胞中的正负相互作用
J Pharmacol Exp Ther. 2016 Oct;359(1):124-33. doi: 10.1124/jpet.116.233379. Epub 2016 Jul 29.
6
Structural insights into ligand recognition by the lysophosphatidic acid receptor LPA.解析配体识别的结构基础:溶血磷脂酸受体 LPA.
Nature. 2017 Aug 17;548(7667):356-360. doi: 10.1038/nature23448. Epub 2017 Aug 9.
7
Endogenous lysophosphatidic acid (LPA ) receptor agonists demonstrate ligand bias between calcium and ERK signalling pathways in human lung fibroblasts.内源性溶血磷脂酸(LPA)受体激动剂在人肺成纤维细胞的钙信号通路和细胞外信号调节激酶(ERK)信号通路之间表现出配体偏向性。
Br J Pharmacol. 2017 Feb;174(3):227-237. doi: 10.1111/bph.13671. Epub 2017 Jan 6.
8
Differential activation mechanisms of lipid GPCRs by lysophosphatidic acid and sphingosine 1-phosphate.溶血磷脂酸和鞘氨醇 1-磷酸对脂质 GPCR 的差异化激活机制。
Nat Commun. 2022 Feb 8;13(1):731. doi: 10.1038/s41467-022-28417-2.
9
Phosphorothioate analogs of sn-2 radyl lysophosphatidic acid (LPA): metabolically stabilized LPA receptor agonists.sn-2 位取代基的硫代磷酸酯类似物赖氨酰溶血磷脂酸(LPA):代谢稳定的 LPA 受体激动剂。
Bioorg Med Chem Lett. 2013 Mar 15;23(6):1865-9. doi: 10.1016/j.bmcl.2013.01.002. Epub 2013 Jan 23.
10
Differential targeting of lysophosphatidic acid LPA, LPA, and LPA receptor signalling by tricyclic and tetracyclic antidepressants.三环和四环抗抑郁药对溶血磷脂酸 LPA、LPA 和 LPA 受体信号的差异靶向作用。
Eur J Pharmacol. 2023 Nov 15;959:176064. doi: 10.1016/j.ejphar.2023.176064. Epub 2023 Sep 25.

引用本文的文献

1
Whole-Genome Sequencing Reveals the Role of Cis-Regulatory Elements and eQTL/sQTL in the Adaptive Selection of Hubei Indigenous Cattle.全基因组测序揭示顺式调控元件和eQTL/sQTL在湖北本地牛适应性选择中的作用。
Animals (Basel). 2025 Apr 30;15(9):1301. doi: 10.3390/ani15091301.
2
Evaluation of Lysophosphatidic Acid Effects and Its Receptors During Bovine Embryo Development.牛胚胎发育过程中溶血磷脂酸的作用及其受体的评估
Int J Mol Sci. 2025 Mar 13;26(6):2596. doi: 10.3390/ijms26062596.

本文引用的文献

1
Cryo-EM structures of human GPR34 enable the identification of selective antagonists.人源 GPR34 的冷冻电镜结构可用于鉴定选择性拮抗剂。
Proc Natl Acad Sci U S A. 2023 Sep 26;120(39):e2308435120. doi: 10.1073/pnas.2308435120. Epub 2023 Sep 21.
2
G protein-biased LPAR1 agonism of prototypic antidepressants: Implication in the identification of novel therapeutic target for depression.典型抗抑郁药对 G 蛋白偏向性 LPAR1 的激动作用:对抑郁症新型治疗靶点的启示。
Neuropsychopharmacology. 2024 Feb;49(3):561-572. doi: 10.1038/s41386-023-01727-9. Epub 2023 Sep 6.
3
Molecular mechanism of fatty acid activation of FFAR1.
脂肪酸激活 FFAR1 的分子机制。
Proc Natl Acad Sci U S A. 2023 May 30;120(22):e2219569120. doi: 10.1073/pnas.2219569120. Epub 2023 May 22.
4
Ligand-induced activation and G protein coupling of prostaglandin F receptor.配体诱导的前列腺素 F 受体的激活和 G 蛋白偶联。
Nat Commun. 2023 May 9;14(1):2668. doi: 10.1038/s41467-023-38411-x.
5
Cryo-EM structure of the endothelin-1-ET-G complex.内皮素-1-ET-G 复合物的冷冻电镜结构。
Elife. 2023 Apr 25;12:e85821. doi: 10.7554/eLife.85821.
6
Structural basis of selective cannabinoid CB receptor activation.选择性大麻素 CB 受体激活的结构基础。
Nat Commun. 2023 Mar 15;14(1):1447. doi: 10.1038/s41467-023-37112-9.
7
Unsaturated bond recognition leads to biased signal in a fatty acid receptor.不饱和键识别导致脂肪酸受体信号偏向。
Science. 2023 Apr 7;380(6640):eadd6220. doi: 10.1126/science.add6220.
8
Structural basis of lysophosphatidylserine receptor GPR174 ligand recognition and activation.溶血磷脂酰丝氨酸受体 GPR174 配体识别和激活的结构基础。
Nat Commun. 2023 Feb 23;14(1):1012. doi: 10.1038/s41467-023-36575-0.
9
Structure of the active G-coupled human lysophosphatidic acid receptor 1 complexed with a potent agonist.活性 G 偶联人溶血磷脂酸受体 1 与有效激动剂复合物的结构。
Nat Commun. 2022 Sep 15;13(1):5417. doi: 10.1038/s41467-022-33121-2.
10
Structure of S1PR2-heterotrimeric G signaling complex.S1PR2-异源三聚体G信号复合物的结构
Sci Adv. 2022 Apr;8(13):eabn0067. doi: 10.1126/sciadv.abn0067. Epub 2022 Mar 30.